Article

Measuring Response to Treatment in Multiple Myeloma

Author(s):

C. Ola Landgren

C. Ola Landgren discusses ways to measure response to treatment in multiple myeloma.

C. Ola Landgren, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses ways to measure response to treatment in multiple myeloma. Landgren addressed this topic in a talk last week at the 33rd Annual Chemotherapy Foundation Symposium, a meeting of over 1,000 physicians and other oncology professionals in New York City.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Dr. D'sa
Understanding the Evolution of Waldenström Macroglobulinemia Treatment
Image of doctor.
Early Arterial Thrombosis May Signal Future Cancer Risk
Image of Dr. Deville.
What are the Long-Term Side Effects of Proton Therapy in Prostate Cancer?
Image of man.
Understanding Unique Treatment Options Across Bladder Cancer Care
Image of kelly.
Preparing For Survivorship After Lymphoma Treatment in AYA PatientsPreparing For Survivorship After Lymphoma Treatment in AYA Patients
Robotic and minimally invasive kidney cancer surgery may reduce pain, shorten recovery time and preserve kidney function, according to Dr. Armine Smith.
Robotic Kidney Cancer Surgery May Aid Recovery, Spare Kidney Function
Image of Doctor.
Long-Term Prostate Cancer Data Highlights Risk and Survivorship Needs
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
Why Relationships are Key When Caring For Patients With MPNs
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Advances in Radiation Improve Precision in Brain Cancer Therapy
Image of Dr. Doug
Expert Shares Key Insights During Melanoma Awareness Month
Related Content
Grace Allison, B.S.N., RN, OCN, RN-BC, and Erin Mensching, RN-B.S.N., OCN
May 18th 2025

Providing Care and Listening With Compassion During Cancer

Grace Allison, B.S.N., RN, OCN, RN-BC
Top Headlines on CAR-T Cell Therapy
December 4th 2023

Top Headlines on CAR-T Cell Therapy

Alex Biese Brielle Benyon
From FDA concerns to a potential new drug, CAR-T cell therapies were dominating oncology headlines last week.
"Advocacy" text.
May 11th 2025

My Health, My Voice: Why Self-Advocacy Is Important

Kristen Rabe
I challenged a mistaken fall risk label before my transplant and proved that self-advocacy is crucial to both quality care and emotional well-being.
Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic
January 13th 2022

Health Care Worker Discusses Cancer Diagnosis and Vaccine Experience While on the Frontlines of the COVID-19 Pandemic

Jamie Cesanek
In this episode of the “Cancer Horizons” podcast, a physician assistant recalls his experience as a frontline health care worker during the COVID-19 pandemic and what it was like to get diagnosed with multiple myeloma during such a chaotic time.
Blood cells.
May 7th 2025

Cemsidomide Generates Results at Multiple Doses in Multiple Myeloma

Ryan Scott
Treatment with cemsidomide resulted in notable responses at multiple dose levels for patients with multiple myeloma
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.